Prova Storytel gratis i 30 dagar Ett universum fyllt av ljudböcker, klicka här för att komma igång

Neurology Today in 5

En podcast av: American Academy of Neurology

Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today highlights the most noteworthy and newsworthy neurology stories in the issue

Our American listeners can also listen to Neurology Today in 5 at our American site

108 Avsnitt

New approved drug for neurofibromatosis 1 with plexiform neurofibromas, multidisciplinary clinics in neurology, impact of cuts to DEI research grants
Publicerades 2025-04-03

Impact of NIH cuts on neurology research, response to ACP’s guideline on migraine, an updated position on seizures, driver licensure, and medical reporting
Publicerades 2025-03-20
Lifetime burden of dementia, hidden features on EEGs for epilepsy detection, neurology-trained pharmacists
Publicerades 2025-03-06
IVF and MS relapse, community-based neurologists doing clinical research, and the loneliness protein implicated in brain function.
Publicerades 2025-02-20
Remote neurology education, tirzepatide for obesity-related OSA, artificial intelligence for glioma assessment
Publicerades 2025-02-06
Middle meningeal artery embolization and subdural hematoma, processed red meat and dementia risk, and editor picks for best neurology advances of 2024.
Publicerades 2025-01-16
Magnesium sulfate for cerebral palsy, novel gene therapy for muscular dystrophies, chronic traumatic encephalitis and suicidality in retired NFL players.
Publicerades 2025-01-02
Revised criteria for diagnosing MS, AI for alleviating administrative burden, neonatal neurocritical care as a growing subspecialty
Publicerades 2024-12-19
3-year outcomes for anti-NMDAR encephalitis, skin biopsies for diagnosis of human prion diseases, the career benefits of graduate degrees in public health and/or business administration
Publicerades 2024-12-05
Cardiovascular effects of antiseizure therapies, social determinants of health on children with MS, coverage for blood-based biomarkers for Alzheimer’s
Publicerades 2024-11-21
Fever prevention and stroke, environmental toxins and Parkinson’s, cholesterol overload and ALS progression
Publicerades 2024-11-07
Blood test for ALS, new migraine target reduces headache days, latest data on eculizumab for neuromyelitis optica spectrum disorder
Publicerades 2024-10-17
Eastern equine encephalitis, systems for anti-amyloid therapies, new protocol for eye stroke
Publicerades 2024-10-03
Brain circuit underlying placebo pain relief, common Parkinson’s gene variants, blood biomarker testing for Alzheimer’s
Publicerades 2024-09-19
Alzheimer’s diagnosis criteria, AI and Parkinson’s severity, neurotoxicity of racism
Publicerades 2024-09-05
Weight loss drugs and optic neuropathy, normothermic regional perfusion, APPs in neurology practice
Publicerades 2024-08-15
Body composition and neurologic disease, Tenecteplase and stroke related-disability, comorbid stroke and cancer
Publicerades 2024-07-31
Antihypertensive and reduced risk for epilepsy, first responders to 9-11 and early dementia risk, FDA approval of donanemab
Publicerades 2024-07-18
Rescue therapies when endovascular thrombectomy fails, the impact of first-seizure clinics on outcomes, AI and sleep neurology
Publicerades 2024-07-04
When to withdraw life support for severe TBI, inflammatory markers score and stroke risk, application overload for neurology residency programs.
Publicerades 2024-06-20

Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today highlights the most noteworthy and newsworthy neurology stories in the issue.

108 Avsnitt

New approved drug for neurofibromatosis 1 with plexiform neurofibromas, multidisciplinary clinics in neurology, impact of cuts to DEI research grants

Impact of NIH cuts on neurology research, response to ACP’s guideline on migraine, an updated position on seizures, driver licensure, and medical reporting

Lifetime burden of dementia, hidden features on EEGs for epilepsy detection, neurology-trained pharmacists

IVF and MS relapse, community-based neurologists doing clinical research, and the loneliness protein implicated in brain function.

Remote neurology education, tirzepatide for obesity-related OSA, artificial intelligence for glioma assessment

Middle meningeal artery embolization and subdural hematoma, processed red meat and dementia risk, and editor picks for best neurology advances of 2024.

Magnesium sulfate for cerebral palsy, novel gene therapy for muscular dystrophies, chronic traumatic encephalitis and suicidality in retired NFL players.

Revised criteria for diagnosing MS, AI for alleviating administrative burden, neonatal neurocritical care as a growing subspecialty

3-year outcomes for anti-NMDAR encephalitis, skin biopsies for diagnosis of human prion diseases, the career benefits of graduate degrees in public health and/or business administration

Cardiovascular effects of antiseizure therapies, social determinants of health on children with MS, coverage for blood-based biomarkers for Alzheimer’s

Fever prevention and stroke, environmental toxins and Parkinson’s, cholesterol overload and ALS progression

Blood test for ALS, new migraine target reduces headache days, latest data on eculizumab for neuromyelitis optica spectrum disorder

Eastern equine encephalitis, systems for anti-amyloid therapies, new protocol for eye stroke

Brain circuit underlying placebo pain relief, common Parkinson’s gene variants, blood biomarker testing for Alzheimer’s

Alzheimer’s diagnosis criteria, AI and Parkinson’s severity, neurotoxicity of racism

Weight loss drugs and optic neuropathy, normothermic regional perfusion, APPs in neurology practice

Body composition and neurologic disease, Tenecteplase and stroke related-disability, comorbid stroke and cancer

Antihypertensive and reduced risk for epilepsy, first responders to 9-11 and early dementia risk, FDA approval of donanemab

Rescue therapies when endovascular thrombectomy fails, the impact of first-seizure clinics on outcomes, AI and sleep neurology

When to withdraw life support for severe TBI, inflammatory markers score and stroke risk, application overload for neurology residency programs.